TrueVision 3D Surgical has been issued a patent by the U.S. Patent & Trademark Office for its computer-guided surgery system for limbal and corneal relaxing incisions during astigmatism-correcting procedures.The system is designed to provide real-time, multidimensional visualizations of target surgical fields with adjustable, positional accuracy and real-time, virtual surgical reference indications that are automatically positioned to make up for motion during the procedure, according to a press release.
Month: July 2014
BLOG: Turning results into action: InflammaDry vs. Tear Osmolarity
How’s it going for you with the InflammaDry? We have used it routinely in our dry eye clinic since shortly before the American Society of Cataract and Refractive Surgery meeting.Essentially, anyone who would have a Tear Osmolarity (TearLab) test performed is also getting an InflammaDry (Rapid Pathogen Screening) test. We are trying to determine several very important things — namely, who should be tested, and what do the results mean? Here’s what we have come up with so far.
Retinal Implants: A Systematic Review
This review highlights some of the advantages and limitations of current retinal prostheses. The British Journal of Ophthalmology
Strabismus Risk Much Higher in Very Low Birth Weight Infants
The risk for strabismus was 14 times higher in very premature infants who weighed less than 2000 g at birth, independent of gestational age. Medscape Medical News
The Premium Channel: Femtosecond laser technology comes a long way over last decade
More than 3 million Americans undergo cataract surgery each year, with more than half of them older than age 65. Cataract surgery as we know it today is one of the safest and most commonly performed surgeries in the United States. The challenges faced by ophthalmologists are higher expectations from our patients because cataract surgery is now treated like refractive surgery and the financial pressures of obtaining LASIK-like outcomes to meet these expectations. Today’s refractive cataract patient is looking at cataract surgery as a chance to have a lifestyle change (Read more...)
Ranibizumab reduces leakage after macular telangiectasia, offers modest BCVA improvement
Although ranibizumab injections helped reduce leakage secondary to macular telangiectasia type 2, improvements in best corrected visual acuity were similar to those seen in the untreated fellow eye, according to study findings.The study included 10 eye…
CEDARS Debates: Surgeons weigh in on accommodating vs. multifocal IOLs
CEDARS Debates is a monthly feature in Ocular Surgery News. CEDARS — Cornea, External Disease, and Refractive Surgery Society — is a group of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.This month, Mitchell A. Jackson, MD, and Quentin B. Allen, MD, discuss the pros and cons of using accommodating IOLs vs. multifocal IOLs for cataract surgery.
Dompe receives orphan drug status for neurotrophic keratitis treatment
The U.S. Food and Drug Administration has granted orphan drug designation for a recombinant human nerve growth factor-based treatment.Recombinant human nerve growth factor (rhNGF, Dompe) is indicated for the treatment of neurotrophic keratitis, a corne…
AL-Scan Optical Biometer granted 510(k) clearance
Nidek has announced that the U.S. Food and Drug Administration has issued 510(k) clearance for the AL-Scan Optical Biometer.The AL-Scan Optical Biometer has the capability to measure axial length, corneal curvature radius, anterior chamber depth, centr…
Researchers develop high-precision software for diagnosing eye sensitivity
Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity.
Robert E. Marc named recipient of 2014 Paul Kayser International Award in Retina Research
Robert E. Marc, Ph.D., director of research at the University of Utah’s John A. Moran Eye Center, has been named by the International Society of Eye Research as the recipient of the Houston, Texas-based Retina Research Foundation’s 2014 Paul Kayser Int…
Distinctive developmental origin for a drainage tube in the eye
A Jackson Laboratory based research team has conducted a comprehensive exploration of an eye structure known as Schlemm’s canal: a key gatekeeper for the proper flow of eye fluid, presenting a…
Lessons for the Practicing Ophthalmologist
You won’t want to miss these highlights of clinical eye research from Wills Eye Hospital. Wills Eye Hospital
ACA provisions upheld by Virginia court, medical societies file amici brief
Two hours after the US Court of Appeals for the District of Columbia ruled in a split decision that provisions of the Affordable Care Act providing tax incentives for low-income citizens to purchase health insurance were unconstitutional, the US Court …
Insignificant link found between genotype, response to AREDS supplements
Genotype had an insignificant association with response to nutritional supplementation, according to study findings.In a retrospective analysis of data from the first AREDS, researchers attempted to gauge whether genotypes at two major loci related to age-related macular degeneration — complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) — had any significant effect on the relative benefits of AREDS supplements in a subset of patients at high risk for progression to late AMD.
US Court of Appeals strikes down key provisions of ACA
In the case of Halbig vs. Burwell, the United States Court of Appeals for the District of Columbia Circuit has ruled that a key piece of the Affordable Care Act involving subsidies to low-income citizens in certain states is unconstitutional. The decis…
NanoVision announces license agreement, technology collaboration with OVI Lens
NanoVision Group announced it has entered into a manufacturing and distribution agreement with OVI Lens, as well as a collaboration for new technological development. Under the agreement, OVI Lens is permitted to manufacture bandage and therapeutic contact lenses under the umbrella of NanoVision. Additionally, the agreement enables NanoVision to distribute OVI’s Quotidia Therapeutic, Quotidia Daily Aloe, Quotidia Therapeutic Aloe and Quotidia Schleral Aloe contact lenses in Asia, Europe and the Middle East on an exclusive or co-exclusive basis starting Sept. 24, according to a press release.
Early stage AMD can occur much earlier than previously thought
It is widely accepted that age-related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countries.
AbbVie to acquire Shire for $54.6 billion
AbbVie announced it has reached an agreement to acquire Shire for $89.56 per share, or about $54.6 billion, according to a company press release.The agreement consists of $41.71 in cash and 0.896 in new AbbVie shares, representing a 53% premium to Shire’s closing price on May 2.
Age-related macular degeneration occurs much earlier than previously assumed
It is widely accepted that age-related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countries.